Fistula First? Fistula Second?
The significant adverse effects on both morbidity and mortality of a tunneled dialysis catheter (TDC) are well-known. Despite these known adverse outcomes, 80% of patients in [...]
fistula
#SCM17 Late-Breaking Abstract: Vonapanitase for Radiocephalic Fistula Patency
Dr. Anthony Bleyer is Professor of Internal Medicine and Nephrology at Wake Forest School of Medicine. He discusses his SCM17 late-breaking abstract, The Effect of [...]
Beyond Predictive Elements for Early Fistula Failure?
Early failure is a major issue in dialysis patients receiving an arteriovenous fistula. It is associated with increased morbidity and costs of medical care. Previously, Lok [...]